Internal Medicine Alert – June 30, 2018
June 30, 2018
View Archives Issues
-
Risk of Endocarditis Revisited
The authors of a population-wide study of hospitalizations and deaths from infective endocarditis (IE) in England confirmed the high risk of IE in certain cardiac conditions, but showed that other conditions thought to be low risk also are at higher risk and found new higher-risk categories not previously identified.
-
Planes, Pathogens, and Passengers: Infection Risk During Commercial Air Travel
Although air travel has been linked to transmission of respiratory infections, the actual risk of becoming infected during air travel is low. The risk is greatest, though, when seated within about two seats/rows of a contagious individual. Walking around the cabin increases the risk.
-
Differences Between Type 1 and Type 2 Diabetic Neuropathy
Microstructural nerve damage in distal symmetric diabetic neuropathy differs between subjects with type 1 diabetes (T1D) and type 2 diabetes (T2D). The predominant nerve lesions in T1D correlated with hyperglycemia and nerve conduction impairment, while the predominant lesions in T2D correlated with dyslipidemia.
-
Erenumab-aooe Injection (Aimovig)
Erenumab-aooe, with a novel mechanism of action, is the first drug approved specifically for the preventive treatment of migraine.